Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Parlodel 10mg capsules
0607010B0BBADAB
|
Parlodel | Bromocriptine | Endocrine System | No data available |
|
Parlodel 1mg tablets
0607010B0BBAAAC
|
Parlodel | Bromocriptine | Endocrine System | No data available |
|
Parlodel 2.5mg tablets
0607010B0BBABAD
|
Parlodel | Bromocriptine | Endocrine System | No data available |
|
Parlodel 5mg capsules
0607010B0BBACAA
|
Parlodel | Bromocriptine | Endocrine System | No data available |
|
Parmid XL 10mg tablets
0206020F0BJABAC
|
Parmid (Felodipine) | Felodipine | Cardiovascular System | No data available |
|
Parmid XL 5mg tablets
0206020F0BJAAAB
|
Parmid (Felodipine) | Felodipine | Cardiovascular System | No data available |
|
Paromomycin 125mg/5ml oral solution
0504050T0AAACAC
|
Paromomycin sulfate | Paromomycin sulfate | Infections | No data available |
|
Paroxetine 20mg/5ml oral liquid
0403030P0AAADAD
|
Paroxetine hydrochloride | Paroxetine hydrochloride | Central Nervous System | No data available |
|
Paroxetine 30mg/5ml oral liquid
0403030P0AAAEAE
|
Paroxetine hydrochloride | Paroxetine hydrochloride | Central Nervous System | No data available |
|
Partobulin SDF 1,250units/1ml inj pre-filled syringes
1405030A0BBADAB
|
Partobulin | Anti-D (Rh-) immunoglobulin | Immunological Products and Vaccines | No data available |
|
Paser gastro-resistant granules 4g sachets
0501090A0BBAAAA
|
Paser | Aminosalicylic acid | Infections | No data available |
|
Pasireotide 10mg inj vials
0803043Q0AAAGAG
|
Pasireotide | Pasireotide | Malignant Disease and Immunosuppression | No data available |
|
Pasireotide 20mg inj vials
0803043Q0AAADAD
|
Pasireotide | Pasireotide | Malignant Disease and Immunosuppression | No data available |
|
Pasireotide 300micrograms/1ml inj ampoules
0803043Q0AAAAAA
|
Pasireotide | Pasireotide | Malignant Disease and Immunosuppression | No data available |
|
Pasireotide 30mg inj vials
0803043Q0AAAHAH
|
Pasireotide | Pasireotide | Malignant Disease and Immunosuppression | No data available |
|
Pasireotide 40mg inj vials
0803043Q0AAAEAE
|
Pasireotide | Pasireotide | Malignant Disease and Immunosuppression | No data available |
|
Pasireotide 600micrograms/1ml inj ampoules
0803043Q0AAABAB
|
Pasireotide | Pasireotide | Malignant Disease and Immunosuppression | No data available |
|
Pasireotide 60mg inj vials
0803043Q0AAAFAF
|
Pasireotide | Pasireotide | Malignant Disease and Immunosuppression | No data available |
|
Pasireotide 900micrograms/1ml inj ampoules
0803043Q0AAACAC
|
Pasireotide | Pasireotide | Malignant Disease and Immunosuppression | No data available |
|
Passion flower 36mg tablets
091200000AAFMFM
|
Generic compound preparation BNF 0912000 | Other health supplement preparations | Nutrition and Blood | No data available |
|
Pasticely gluten free part baked white baguettes
0904010H0BQACAA
|
Pasticely (Gluten free bread) | Gluten free breads | Nutrition and Blood | No data available |
|
Pasticely gluten free part baked white rolls
0904010H0BQABAA
|
Pasticely (Gluten free bread) | Gluten free breads | Nutrition and Blood | No data available |
|
Pasticely gluten free part baked white rustic rolls
0904010H0BQAFAA
|
Pasticely (Gluten free bread) | Gluten free breads | Nutrition and Blood | No data available |
|
Pasticely gluten free pasta elbows
0904010Q0BKABAQ
|
Pasticely (Gluten free pasta) | Gluten free pastas | Nutrition and Blood | No data available |
|
Pasticely gluten free pasta macaroni
0904010Q0BKACAQ
|
Pasticely (Gluten free pasta) | Gluten free pastas | Nutrition and Blood | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.